New guidelines for the management of thyroid nodules and differentiated thyroid cancer

Minerva Endocrinologica

Volumn 36, Issue 1, 2011, Pages 53-70

  Milas, Z ^a   Shin, J ^b   Milas, M ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Guidelines as topic; Iodine radioisotopes; Risk assessment; Thyroid cancer, papillary; Thyroid neoplasms

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 123; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; THYROTROPIN;

ASPIRATION BIOPSY; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SCINTISCANNING; CANCER SIZE; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIATED THYROID CANCER; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; ECHOGRAPHY; HEALTH CARE ORGANIZATION; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL HISTORY; NECK DISSECTION; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; REVIEW; THYROID CARCINOMA; THYROID NODULE; THYROID SCINTISCANNING; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TREATMENT PLANNING;

ALGORITHMS; EVIDENCE-BASED MEDICINE; HUMANS; NECK DISSECTION; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK ASSESSMENT; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 79959929037     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 1996;156:2165-72. (Pubitemid 26361908)
2. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-42.
3. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803. (Pubitemid 43997716)
4. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214.
5. Tuttle RM, Ball DW, Byrd D, Dilawari RA, Doherty GM, Duh QY et al. NCCN Clinical practice guidelines in oncology. Version 1:2011. Journal of the National Comprehensive Cancer Network, 2010;8:1228-1274. (also available on www.NCCN.org)
6. Carty SE, Cooper DS, Doherty GM, Duh QY, Kloos RT, Mandel SJ et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009; 19: 1153-8.
7. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19:565-612.
8. Wartofsky L. Highlights of the American Thyroid Association Guidelines for patients with thyroid nodules or differentiated thyroid carcinoma: the 2009 revision. Thyroid 2009;19:1139-43.
9. Hartl DM, Travagli JP. The updated American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: a surgical perspective. Thyroid 2009;19:1149-51
10. Puxeddu E, Filetti S. The 2009 American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: progress on the road from consensus- to evidence-based practice. Thyroid 2009;19:1145-7.
11. Ogilvie JB, Patel KN, Heller KS. Impact of the 2009 American Thyroid Association guidelines on the choice of operation for well-differentiated thyroid microcarcinomas. Surgery 2010;148:1222-6.
12. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med 2004;351:1764-71.
13. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1997;7:481-93.
14. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 1968;69:537-40.
15. Mandel Sj. A 64-year-old woman with a thyroid nodule. JAMA 2004:292;2632-42.
16. Tuttle RM. Risk-adapted management of thyroid cancer. Endocr Pract 2008;14:764-74.
17. Tuttle RM, Leboeuf R. Follow up approaches in thyroid cancer: a risk adapted paradigm. Endocrinol Metab Clin North Am 2008;37:419-35. (Pubitemid 351698090)
18. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006;91:4295-301. (Pubitemid 44833401)
19. Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 2006;91:3411-7. (Pubitemid 44402112)
20. Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH et al. Benign and malignant thyroid nodules: US differentiation - multicenter retrospective study. Radiology 2008;247:762-70.
21. Bonavita JA, Mayo J, Babb J, Bennett G, Oweity T, Macari M et al. Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone? AJR Am J Roentgenol 2009;193:207-13.
22. Mazzaferri EL, Sipos J. Should all patients with subcentimeter thyroid nodules undergo fine-needle aspiration biopsy and preoperative neck ultrasonography to define the extent of tumor invasion? Thyroid 2008;18:597-602.
23. Ali SZ, Cibas ES, editors. The Bethesda system for reporting thyroid cytopathology: definitions, criteria and explanatory notes. New York: Springer; 2010.
24. Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 2007;111:306-15.
25. 18FDG-PET/CT. Surgery 2005;138:1166-74.
26. Carmeci C, Jeffrey RB, McDougall IR, Nowels KW, Weigel RJ. Ultrasound-guided fine-needle aspiration biopsy of thyroid masses. Thyroid 1998;8:283-9. (Pubitemid 28198720)
27. Ylagan LR, Farkas T, Dehner LP. Fine needle aspiration of the thyroid: a cytohistologic correlation and study of discrepant cases. Thyroid 2004;14:35-41. (Pubitemid 38282935)
28. McCoy KL, Jabbour N, Ogilvie JB, Ohori NP, Carty SE, Yim JH. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery 2007;142:837-44. (Pubitemid 350184095)
29. Asanuma K, Kobayashi S, Shingu K, Hama Y, Yokoyama S, Fujimori M et al. The rate of tumour growth does not distinguish between malignant and benign thyroid nodules. Eur J Surg 2001;167:102-5. (Pubitemid 32198115)
30. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Database report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;83:2638-2648.
31. Silver CE, Owen RP, Rodrigo JP, Rinaldo A, Devaney KO, Ferlito A. Aggressive variants of papillary thyroid carcinoma. Head Neck 2010 [Epub ahead of print].
32. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999;9:421-7. (Pubitemid 29244917)
33. Kouvarki MA, Shapiro SE, Fornage BD, Ediken-Monro BS, Sherman SI, Vassilopoulou-Sellin R et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 2003;134:946-54.
34. Milas M, Stephen A, Berber E, Wagner K, Miskulin J, Siperstein A. Ultrasonography for the endocrine surgeon: a valuable clinical tool that enhances diagnostic and therapeutic outcomes. Surgery 2005;138:1193-2000.
35. Grebe SK, Hay ID. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin North Am 1996;5:43-63. (Pubitemid 26047382)
36. Scheumann GF, Gimm O, Wgener G, Hudeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559-68 (Pubitemid 24273857)
37. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381-7.
38. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid - prognostic significance of lymph node metastasis and multifocality. Cancer 2003;98:31-40. (Pubitemid 36741122)
39. Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope 2010 Dec 1 [Epub ahead of print].
40. Lew JI, Solorzano CC. Use of ultrasound in the management of thyroid cancer. Oncologist 2010;15:253-8.
41. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine needle aspiration cytology. Diagn Cytopathol 2002;26:41-4.
42. Sclabas GM, Staerkel GA, Shapiro SE, Fornage BD, Sherman SI et al. Fine needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg 2003;186:702-9.
43. Bilimoria KY, Bentrem DJ, Linn JG, Freel A, Yeh JJ, Stewart AK et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 2007;142:906-13. (Pubitemid 350184098)
44. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003;237:399-407. (Pubitemid 38176456)
45. Pereira JA, jimeno J, Miquel J, Iglesias M, Munné A, Sancho JJ et al. Nodal yield, morbidity and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 2005;138:1095-100.
46. Tissell LE, Nilsson B, Molne J, Hansson G, Fjalling M, Jansson S et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 1996;20:854-9. (Pubitemid 26281914)
47. Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006;140:1000-7. (Pubitemid 44937385)
48. Cavicchi O, Piccin O, Caliceti U, De Cataldis A, Pasquali R, Ceroni AR. Transient hypoparathyroidism following thyroidectomy: a prospective study and multivariate analysis of 604 patients. Oto Head Neck Surg 2007;137:654-8.
49. Roh JL, Park Jy Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 2007;245:604-10.
50. Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 2010;148:1100-6.
51. Urken ML. Management of well-differentiated thyroid cancer in 2010: Perspectives of a head and neck surgical oncologist. Endocrine Practice 2010;5:903-12.
52. Ross DS, Litofsky D, Ain KB, Bigos T, Brierley JD, Cooper DS et al. Recurrence after treatment of micropapillary thyroid cancer. Thyroid 2009;19:1043-8.
53. Pacini F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT et al. Radioactive iodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized controlled study. J Clin Endocrinol Metab 2006,91:926-32. (Pubitemid 43357760)
54. Park HM, Park YH Zhou XH. Detection of thyroid remnant/metastasis without stunning: an ongoing dilemma. Thyroid 1997;7:277-80.
55. 131I scanned and nonscanned individuals. J Clin Endocrinol Metab 2001;86:3507-11. (Pubitemid 32755936)
56. Pujol P, Daures JP, Nsakala N, Baldet L, Bringer J, Jaffiol C. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996;81:4318-23. (Pubitemid 26412036)
57. Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 2006;16:1229-42. (Pubitemid 46080167)
58. Mazzaferri EL, Kloos RT Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 2002;87:1490-8.
59. Shin JJ, Milas M. Detection of disease recurrence in differentiated thyroid cancer. Minerva Chir 2010;65:101-16.
60. Sherman SI. Targeted therapy of thyroid cancer. Biochem Pharmacol 2010;80:592-601.
61. Sherman SI. Cytotoxic chemotherapy for differentiated thyroid carcinoma. Clin Oncol (R Coll Radiol) 2010;22:464-8.
62. Milas M, Shin J, Gupta M, Novosel T, Nasr C, Brainard J et al. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples. Ann Surg 2010;252:643-51.
63. Chudova D, Wilde JI, Wang ET, Wang H, Rabbee N, Egidio CM et al. Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab 2010;95:5296-304.
64. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 2009;94:2092-8.
65. Yip L, Kebebew E, Milas M, Carty SE, Fahey TJ 3rd, Parangi S et al. Summary statement: utility of molecular marker testing in thyroid cancer. Surgery 2010;148:1313-5.
66. Wang TS, Evans DB. The importance of a multidisciplinary approach to endocrine tumors. Surgery 2010;148:1311-2.
67. Grubbs EG, Waguespack SG, Rich TA, Xing Y, Ying AK, Evans DB et al. Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A? Surgery 2010;148:1302-9.
68. Frates MC, Langer JE. Biopsy of thyroid nodules: comparison of three sets of guidelines. AJR Am J Roentgenol 2010;195:W472.
69. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L et al. AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Invest 2010;33(5 Suppl):51-6.
70. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L et al. AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. J Endocrinol Invest 2010;33(5 Suppl):1-50.
71. Wu LS, Roman SA, Sosa JA Medullary thyroid cancer: an update of new guidelines and recent developments. Curr Opin Oncol 2010 Oct 30. [Epub ahead of print].
72. Miller BS, Doherty GM. An examination of recently revised differentiated thyroid cancer guidelines. Curr Opin Oncol 2010 [Epub ahead of print).